The pharmacy job market is tighter than it was a decade ago, but calling it “oversaturated” oversimplifies a complicated picture. The Bureau of Labor Statistics projects pharmacist employment to grow 5% from 2024 to 2034, which is actually faster than the average for all occupations. About 14,200 openings are expected each year. At the same time, massive retail chain closures, high pharmacy school acceptance rates, and uneven geographic demand create real pressure points that make the field feel saturated in certain areas and for certain roles.
What the Federal Data Actually Shows
There are roughly 335,100 pharmacists working in the U.S. as of 2024. That number is projected to reach 350,500 by 2034, an increase of about 15,400 positions. The median annual salary sits at $136,030, with the top 10% earning above $168,650 and the bottom 10% earning under $90,000. These are not the numbers of a dying profession, but the growth is modest, and compensation has been relatively flat when adjusted for inflation over recent years.
The more telling federal projection comes from the Health Resources and Services Administration, which models long-term workforce supply against patient demand. HRSA projects a shortage of 30,400 pharmacists by 2038. That forecast may seem hard to square with the feeling of oversaturation, but it reflects something important: the problem isn’t too many pharmacists in total. It’s too many pharmacists concentrated in the same types of jobs and the same geographic areas.
Too Many Graduates, Not Enough Selectivity
One of the clearest signs of imbalance is how easy it has become to get into pharmacy school. According to the American Association of Colleges of Pharmacy, acceptance rates for PharmD programs now exceed 80%. For comparison, medical schools accept roughly 40% of applicants, and dental schools hover around 55%. An 80%+ acceptance rate means pharmacy schools are admitting nearly everyone who applies, which raises questions about whether supply is being calibrated to actual labor market demand or simply to keep programs financially viable.
Applications did tick up recently, jumping 6% for the Fall 2025 cycle, and the incoming class appears stronger on paper. Nearly half of applicants already held a bachelor’s degree or higher, and half of those accepted had worked as pharmacy technicians before applying. But a short-term uptick in applications doesn’t resolve the structural issue: for years, pharmacy schools have been producing graduates faster than the traditional job market can absorb them, particularly in retail.
Retail Pharmacy Is Shrinking Fast
The most visible source of anxiety is the wave of store closures sweeping the three largest retail pharmacy chains. CVS closed 900 stores between 2022 and 2024 and plans to close another 270 in 2025. Walgreens announced in October 2024 that it would shutter approximately 1,200 locations over three years, starting with 500 in fiscal year 2025 alone. Rite Aid filed for Chapter 11 bankruptcy for the second time in May 2025, with 316 stores already identified for closure.
These closures are driven by slumping consumer spending, low reimbursement rates from insurers, and a broader shift in how people access medications. Each closed store eliminates at least one, and often two or three, pharmacist positions. Since retail pharmacy has historically employed the largest share of pharmacists in the country, losing thousands of storefronts in a short window creates a genuine crunch for new graduates who expected to walk into a retail career. If you’re a pharmacist in a metro area with multiple chain closures, the local job market can absolutely feel oversaturated even while national projections look stable.
Geography Matters More Than People Realize
Over 50 million Americans, about 17.7% of the population, live in what researchers call pharmacy deserts: census tracts without adequate access to a pharmacy. These are overwhelmingly rural and underserved communities. In those areas, there is no oversaturation. There are genuine shortages, and pharmacists willing to relocate can find strong demand and, in many cases, better compensation or loan repayment incentives.
The saturation problem is concentrated in mid-size and large cities where pharmacy schools are located and where graduates prefer to stay. Urban and suburban markets in states with multiple pharmacy programs can have more qualified pharmacists than available positions, while rural counties an hour away struggle to staff a single pharmacy. This geographic mismatch is a major reason national statistics can show projected growth and shortages while individual job seekers in popular areas face stiff competition.
Residency Competition Tells the Story
For pharmacists pursuing clinical roles in hospitals or specialty settings, the bottleneck shows up clearly in residency match data. In 2024, 4,756 applicants participated in the PGY1 pharmacy residency match, and 3,530 matched. That means roughly 26% of applicants didn’t land a position. For PGY2 (specialty) residencies, 934 applied and 722 matched, leaving about 23% without a spot.
A one-in-four failure rate isn’t catastrophic compared to some medical specialties, but it represents a real barrier for graduates who specifically pursued pharmacy to work in clinical care. Those who don’t match often end up in retail or other roles they didn’t plan for, adding to the perception of oversaturation in those segments. The number of residency positions has been expanding, but not fast enough to keep pace with the number of graduates who want them.
Where the Growth Is
The pharmacists finding the most opportunity right now are the ones looking beyond the traditional retail counter. Ambulatory care clinics, where pharmacists manage chronic disease medications alongside physicians, are expanding in health systems across the country. Provider status legislation in several states now allows pharmacists to prescribe certain medications, conduct health screenings, and manage therapy independently, roles that didn’t exist at scale ten years ago.
Managed care organizations, pharmaceutical companies, and health technology firms also employ pharmacists in roles focused on drug utilization review, formulary management, and medication safety. These positions typically require additional training or experience but offer career paths that aren’t subject to the same retail pressures. The pharmacists most vulnerable to oversaturation are those competing for a shrinking pool of traditional dispensing jobs. Those who build clinical skills, pursue residencies, or move into non-traditional sectors face a very different market.
The Bottom Line on Saturation
Pharmacy is not uniformly oversaturated, but it is unevenly distributed in ways that create real problems for specific groups of people. If you’re a new graduate looking for a retail chain position in a major metro area, competition is fierce and getting worse as stores close. If you’re open to rural practice, clinical specialization, or non-traditional roles, the outlook is considerably better, and federal projections suggest demand will outstrip supply within the next 10 to 15 years.
The profession is in the middle of a structural transition. The retail dispensing model that employed the majority of pharmacists for decades is contracting, while clinical, consultative, and technology-driven roles are expanding. How saturated the field feels depends almost entirely on which part of it you’re trying to enter and where you’re willing to go.